More about Gland Pharma Limited
Fundamentals for Gland Pharma Limited
Regulatory Filings for Gland Pharma Limited
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
Technicals for Gland Pharma Limited
Price Summary
2026-04-30, saw GLAND's stock open at 1747.5, hit a peak of 1767.3, fall to a low of 1728.4, and close up 0.19% at 1750.8, with 221258 shares changing hands.Throughout the 52-week period, the stock hit a high of 2102.1 and a low of 1403.5.
13 analysts predict that the future price of GLAND will be in the range of 1575.0 to 2500.0, with a mean expected price of about 1966.6154.
Technicals
Support and Resistance: The current price of 1750.8 for GLAND finds support at 1666.3 and resistance at 1769.8. These levels define a range in which the price might oscillate, with 1666.3 as a potential support and 1769.8 as a resistance level.Aroon: The AROON is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
Parabolic SAR: The PSAR remains in a bearish mode, establishing a resistance level that could hinder any attempts at upward movement for GLAND. This resistance reinforces the bearish sentiment, indicating that the market may continue to face challenges in pushing higher.
Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position for Gland Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook